These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 8092117)
1. Neuron-specific enolase as a tumor marker in metastatic melanoma. Buzaid AC; Sandler AB; Hayden CL; Scinto J; Poo WJ; Clark MB; Hotchkiss S Am J Clin Oncol; 1994 Oct; 17(5):430-1. PubMed ID: 8092117 [TBL] [Abstract][Full Text] [Related]
2. Neuron-specific enolase as a prognostic factor in metastatic malignant melanoma. Wibe E; Hannisdal E; Paus E; Aamdal S Eur J Cancer; 1992; 28A(10):1692-5. PubMed ID: 1389487 [TBL] [Abstract][Full Text] [Related]
3. Neuron specific enolase (NSE) in serum of patients with malignant melanoma. Wibe E; Paus E; Aamdal S Cancer Lett; 1990 Jun; 52(1):29-31. PubMed ID: 2354416 [TBL] [Abstract][Full Text] [Related]
4. S-100 and NSE as serum markers in melanoma. Tofani A; Cioffi RP; Sciuto R; Rea S; Festa A; Di Filippo F; Cavaliere R; Maini CL Acta Oncol; 1997; 36(7):761-4. PubMed ID: 9490097 [TBL] [Abstract][Full Text] [Related]
5. [Neuron-specific enolase: a serum marker of clinical progression for metastatic malignant melanoma]. Guo HB; Stoffel-Wagner B; Brennemann W; Springer W; Klingmüller D J Tongji Med Univ; 1995; 15(1):19-25. PubMed ID: 7783258 [No Abstract] [Full Text] [Related]
14. Pretreatment serum level of neuron specific enolase (NSE) as a prognostic factor in metastatic prostate cancer patients treated with endocrine therapy. Kamiya N; Akakura K; Suzuki H; Isshiki S; Komiya A; Ueda T; Ito H Eur Urol; 2003 Sep; 44(3):309-14; discussion 314. PubMed ID: 12932928 [TBL] [Abstract][Full Text] [Related]
15. Serum neuron-specific enolase is a useful tumor marker for small cell lung cancer. Burghuber OC; Worofka B; Schernthaner G; Vetter N; Neumann M; Dudczak R; Kuzmits R Cancer; 1990 Mar; 65(6):1386-90. PubMed ID: 2155054 [TBL] [Abstract][Full Text] [Related]
16. Serum neuron-specific enolase in children with neuroblastoma. Relationship to stage and disease course. Zeltzer PM; Marangos PJ; Evans AE; Schneider SL Cancer; 1986 Mar; 57(6):1230-4. PubMed ID: 3002599 [TBL] [Abstract][Full Text] [Related]
17. Neuron-specific enolase as a follow-up marker in small cell bronchial carcinoma. A prospective study in an unselected series. Nõu E; Steinholtz L; Bergh J; Nilsson K; Påhlman S Cancer; 1990 Mar; 65(6):1380-5. PubMed ID: 2155053 [TBL] [Abstract][Full Text] [Related]
18. Chromogranin A and neurone-specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration-resistant prostate cancer. Fan L; Wang Y; Chi C; Pan J; Xun S; Xin Z; Hu J; Zhou L; Dong B; Xue W BJU Int; 2017 Aug; 120(2):226-232. PubMed ID: 28107595 [TBL] [Abstract][Full Text] [Related]